Agilent Technologies, Inc. (NYSE:A) Shares Bought by NewEdge Wealth LLC

NewEdge Wealth LLC raised its holdings in Agilent Technologies, Inc. (NYSE:AGet Rating) by 3.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,564 shares of the medical research company’s stock after buying an additional 1,236 shares during the period. NewEdge Wealth LLC’s holdings in Agilent Technologies were worth $4,937,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bromfield Sneider Wealth Advisors acquired a new stake in shares of Agilent Technologies during the second quarter worth about $31,000. Penserra Capital Management LLC acquired a new stake in shares of Agilent Technologies during the first quarter worth about $60,000. WFA of San Diego LLC acquired a new stake in shares of Agilent Technologies during the second quarter worth about $62,000. Clear Street Markets LLC increased its position in shares of Agilent Technologies by 408.1% during the second quarter. Clear Street Markets LLC now owns 625 shares of the medical research company’s stock worth $74,000 after purchasing an additional 502 shares in the last quarter. Finally, Hoey Investments Inc. increased its position in shares of Agilent Technologies by 210.1% during the second quarter. Hoey Investments Inc. now owns 738 shares of the medical research company’s stock worth $88,000 after purchasing an additional 500 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In other news, VP Padraig Mcdonnell sold 2,506 shares of the company’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $134.33, for a total transaction of $336,630.98. Following the completion of the sale, the vice president now directly owns 15,320 shares in the company, valued at approximately $2,057,935.60. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO Michael R. Mcmullen sold 6,775 shares of the company’s stock in a transaction on Wednesday, October 26th. The stock was sold at an average price of $134.43, for a total transaction of $910,763.25. Following the completion of the sale, the chief executive officer now directly owns 191,358 shares in the company, valued at approximately $25,724,255.94. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Padraig Mcdonnell sold 2,506 shares of the company’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $134.33, for a total value of $336,630.98. Following the sale, the vice president now owns 15,320 shares of the company’s stock, valued at $2,057,935.60. The disclosure for this sale can be found here. In the last three months, insiders sold 174,326 shares of company stock worth $26,474,537.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Cowen boosted their price target on Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday, November 22nd. Citigroup boosted their price target on Agilent Technologies from $145.00 to $150.00 and gave the company a “neutral” rating in a research report on Tuesday, November 22nd. SVB Leerink boosted their price target on Agilent Technologies from $145.00 to $160.00 and gave the company an “outperform” rating in a research report on Tuesday, November 22nd. KeyCorp boosted their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research report on Tuesday, November 22nd. Finally, Robert W. Baird boosted their price target on Agilent Technologies from $160.00 to $170.00 in a research report on Tuesday, November 22nd. Four investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $157.00.

Agilent Technologies Price Performance

A stock opened at $154.98 on Thursday. Agilent Technologies, Inc. has a 1 year low of $112.52 and a 1 year high of $162.62. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.47 and a current ratio of 2.03. The stock’s 50 day moving average price is $135.86 and its 200 day moving average price is $129.64. The firm has a market cap of $45.88 billion, a P/E ratio of 37.17, a PEG ratio of 2.67 and a beta of 1.06.

Agilent Technologies (NYSE:AGet Rating) last posted its earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.14. Agilent Technologies had a return on equity of 30.31% and a net margin of 18.31%. The firm had revenue of $1.85 billion for the quarter, compared to analyst estimates of $1.76 billion. During the same quarter in the prior year, the company earned $1.21 EPS. Agilent Technologies’s revenue was up 11.4% on a year-over-year basis. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.64 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Shareholders of record on Tuesday, January 3rd will be issued a $0.225 dividend. The ex-dividend date is Friday, December 30th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. This represents a $0.90 annualized dividend and a yield of 0.58%. Agilent Technologies’s payout ratio is 20.14%.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Recommended Stories

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.